Robotic Partial Nephrectomy with En Bloc Removal of a Renal Vein Thrombus for Multiple cT3a Renal Cell Carcinoma Lesions

肾切除术 医学 肾细胞癌 血栓 外科 肾静脉 肾癌 围手术期 机械人手术 肾脏疾病 放射科 内科学
作者
Antonio Andrea Grosso,Diego Marcos Marìn,Fabrizio Di Maida,Maria Lucia Gallo,Luca Lambertini,Samuele Nardoni,Andrea Mari,Andrea Minervini
出处
期刊:European urology open science [Elsevier BV]
卷期号:44: 33-36 被引量:9
标识
DOI:10.1016/j.euros.2022.08.002
摘要

Partial nephrectomy (PN) may be recommended for selected patients with advanced-stage (>cT2) renal cell carcinoma (RCC) with the aim of avoiding dialysis and chronic kidney disease-related comorbidities. The spread of robotic surgery has led to expansion of PN indications to more challenging scenarios and even frontier surgeries, including advanced-stage RCC. Here we describe the management of a patient with a solitary kidney diagnosed with multiple cT3a (renal vein thrombus) RCC who was treated using a conservative robotic approach. The most crucial surgical considerations for this procedure were: (1) tailored planning of the surgical approach using three-dimensional reconstruction software; (2) accurate boundary delineation for the tumors and thrombus; (3) avoiding unnecessary warm ischemia time; (4) performing an anatomical excision to follow eventual tumor bulging; and (5) en bloc removal of the main lesion and its thrombus. No perioperative complications were recorded. Histopathology revealed clear cell RCC for all four lesions with nucleolar grade 3 and negative surgical margins. At 12-mo follow-up the patient was disease-free. When performed by an experienced surgeon, PN plus venous thrombus excision for imperative cases with cT3 RCC may represent a valid treatment option with valuable oncological and functional outcomes.We describe the case of patient who had a single kidney with multiple kidney tumors and tumor extension into a blood vessel. The patient was treated with robot-assisted removal of the tumors, sparing as much kidney tissue as possible. This technique was found to be safe and effective, with no complications and good intermediate-term results.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李健应助lory采纳,获得10
刚刚
刚刚
超帅妙竹发布了新的文献求助10
刚刚
2秒前
善学以致用应助务实大神采纳,获得10
2秒前
乐观依云完成签到,获得积分10
2秒前
3秒前
4秒前
4秒前
yym发布了新的文献求助10
6秒前
卡比兽发布了新的文献求助10
6秒前
丘比特应助ccl采纳,获得10
6秒前
芭乐发布了新的文献求助10
6秒前
7秒前
AZURE完成签到,获得积分10
8秒前
10秒前
AZURE发布了新的文献求助10
11秒前
choy发布了新的文献求助10
11秒前
Ava应助飘零枫叶采纳,获得10
11秒前
Zac发布了新的文献求助10
12秒前
辞羽发布了新的文献求助10
12秒前
张萌洁发布了新的文献求助10
12秒前
吴彦祖发布了新的文献求助10
12秒前
lxr发布了新的文献求助10
13秒前
13秒前
14秒前
14秒前
15秒前
15秒前
打打应助科研通管家采纳,获得10
15秒前
天天快乐应助科研通管家采纳,获得10
15秒前
Orange应助科研通管家采纳,获得10
15秒前
充电宝应助科研通管家采纳,获得10
15秒前
瑶瑶大王应助科研通管家采纳,获得10
15秒前
Akim应助科研通管家采纳,获得10
15秒前
李爱国应助科研通管家采纳,获得10
15秒前
16秒前
无花果应助hyxu678采纳,获得10
16秒前
情怀应助小霖采纳,获得10
16秒前
CXSCXD发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 3000
Les Mantodea de guyane 2500
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 2000
What is the Future of Psychotherapy in a Digital Age? 700
The Psychological Quest for Meaning 600
Zeolites: From Fundamentals to Emerging Applications 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5955522
求助须知:如何正确求助?哪些是违规求助? 7167831
关于积分的说明 15938896
捐赠科研通 5090542
什么是DOI,文献DOI怎么找? 2735708
邀请新用户注册赠送积分活动 1696585
关于科研通互助平台的介绍 1617347